Real-time enrollment status for this proliferative vitreoretinopathy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 6:11 AM UTC
| NCT Number | NCT06541574 |
| Recruiting Status | Recruiting |
| Condition | Proliferative Vitreoretinopathy |
| Phase | PHASE2 |
| Target Enrollment | 860 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Cincinnati Eye Institute, Southwest Ohio |
| Last Updated on CT.gov | September 19, 2024 (Sep 19, 2024) |
As of July 17, 2026: Clinical trial NCT06541574 is currently recruiting participants. This phase2 study for proliferative vitreoretinopathy is actively seeking new participants at 1 location across the United States. The study is sponsored by Cincinnati Eye Institute, Southwest Ohio. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06541574 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06541574 was last updated Sep 19, 2024 (September 19, 2024). HelloStudys verifies this status automatically.